Revolution Medicines, Inc. RVMD Q2 2025 earnings
Reported August 6, 2025 · After market close
Revenue estimate$27.5M
EPS estimate-$0.94
Next report
Aug 5, 2026 (In 3 weeks)Revenue estimate$17.8M
EPS estimate-$1.96
Financials
Q2 2025Valuation & ratios
Versus estimates
Diluted EPS
Ask the moment Revolution Medicines, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Revolution Medicines, Inc. report Q2 2025 earnings?
- Revolution Medicines, Inc. (RVMD) reported Q2 2025 earnings on August 6, 2025 after market close.
- What were Revolution Medicines, Inc.'s Q2 2025 revenue and EPS?
- Revolution Medicines, Inc. reported revenue of - and diluted EPS of $-1.31 for Q2 2025.
- Did Revolution Medicines, Inc. beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $27.5M by $27.5M. EPS missed the consensus estimate of $-0.94 by $0.37.
- How did Revolution Medicines, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 61.7% from $-0.81.
- Where can I find Revolution Medicines, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-104022) directly on SEC EDGAR. The filing index links above go to sec.gov.